结核与肺部疾病杂志 ›› 2020, Vol. 1 ›› Issue (1): 45-48.doi: 10.3969/j.issn.2096-8493.2020.01.010

• 论著 • 上一篇    下一篇

肺保护性通气策略在肺结核并发HIV感染者机械通气中的应用研究

毛毅, 吴桂辉(), 陈娟, 陈洪德   

  1. 610061 成都市公共卫生临床医疗中心结核科
  • 收稿日期:2020-03-23 出版日期:2020-06-30 发布日期:2020-07-07
  • 通信作者: 吴桂辉 E-mail:wghwgh2584@sina.com
  • 基金资助:
    成都市科技惠民项目(2015-HM01-00479-SF)

Application of lung protective ventilation strategy in mechanical ventilation of patients with pulmonary tuberculosis complicated with HIV infection

MAO Yi, WU Gui-hui(), CHEN Juan, CHEN Hong-de   

  1. Department of Tuberculosis, Public Health Clinical Center of Chengdu, Chengdu 610031, China
  • Received:2020-03-23 Online:2020-06-30 Published:2020-07-07
  • Contact: WU Gui-hui E-mail:wghwgh2584@sina.com

摘要:

目的 探讨肺保护性通气策略在肺结核并发HIV感染者机械通气治疗中的应用价值及其对患者预后的影响。方法 搜集2013年1月至2018年12月于成都市公共卫生临床医疗中心结核重症监护病区住院且接受机械通气治疗的42例肺结核并发HIV感染患者进行回顾性研究,其中,采用肺保护性通气策略治疗的21例患者为观察组,采用常规机械通气治疗的21例患者为对照组。观察组予以肺保护性通气策略下机械通气治疗[潮气量为6~8ml/kg,呼气末正压通气(PEEP)为5~10cm H2O(1cm H2O=0.098kPa)],对照组予以常规机械通气治疗(潮气量为10~12ml/kg,PEEP为0~4cm H2O)。对比两组患者机械通气治疗前后血气分析指标变化情况,以及平均机械通气时间、呼吸机所致肺损伤(VILI)发生率、呼吸机相关性肺炎(VAP)发生率、死亡率差异。结果 机械通气治疗2h后,观察组氧合指数为(250.62±21.45)mm Hg(1mm Hg=0.133kPa),优于对照组的(218.23±18.63)mm Hg,差异有统计学意义(t=21.56,P=0.028)。观察组平均通气时间为(4.92±1.13)d,明显短于对照组的(8.74±2.35)d,差异有统计学意义(t=2.73,P=0.033)。观察组VILI发生率为4.8%(1/21),明显低于对照组的19.0%(4/21),差异有统计学意义(Fisher精确概率法,P=0.027);观察组VAP发生率为9.5%(2/21),明显低于对照组的28.6%(6/21),差异有统计学意义(Fisher精确概率法,P=0.031)。结论 肺保护性通气策略在改善肺结核并发HIV感染患者机械通气治疗效果,降低VILI及VAP发生率,缩短机械通气治疗时间等方面优于常规通气策略。

关键词: 结核,肺, HIV, 共病现象, 呼吸,人工, 治疗结果, 对比研究

Abstract:

Objective To explore the application value of lung protective ventilation strategy in mechanical ventilation treatment of patients with pulmonary tuberculosis (PTB) complicated with human immunodeficiency virus (HIV) infection and its effect on the prognosis of patients. Methods A retrospective study of 42 patients with PTB complicated with HIV infection who were hospitalized in the tuberculosis intensive care ward of the Chengdu Public Health Clinical Medical Center from January 2013 to December 2018 was conducted, including 21 patients treated with lung protective ventilation strategy as the observation group, and the 21 patients treated with conventional mechanical ventilation as the control group. The patients of the observation group were treated with mechanical ventilation under the lung protective ventilation strategy (tidal volume of 6-8 ml/kg, positive end-expiratory pressure (PEEP) of 5-10 cm H2O (1 cm H2O=0.098 kPa)), while the patients of the control group were treated with conventional mechanical ventilation (tidal volume of 10-12 ml/kg, PEEP of 0-4 cm H2O). The changes of blood gas analysis indexes before and after mechanical ventilation treatment, as well as the differences in mean mechanical ventilation time, incidence of lung injury (VILI) caused by ventilator, incidence and mortality of ventilators associated pneumonia (VAP) were compared between the two groups. Results After 2 h of mechanical ventilation treatment, the oxygenation index of the observation group was (250.62±21.45) mm Hg (1 mm Hg=0.133 kPa), which was better than that of the control group ((218.23±18.63) mm Hg), and the difference was statistically significant (t=21.56, P=0.028). The average ventilation time in the observation group was (4.92±1.13) d, which was significantly shorter than that in the control group ((8.74±2.35) d), and the difference was statistically significant (t=2.73, P=0.033). The incidence of VILI in the observation group was 4.8% (1/21), which was significantly lower than that in the control group (19.0% (4/21)), and the difference was statistically significant (Fisher exact probability, P=0.027). The incidence of VAP in the observation group was 9.5% (2/21), which was significantly lower than that in the control group (28.6% (6/21)), with the statistically significant difference (Fisher exact probability, P=0.031). Conclusion The lung protective ventilation strategy is superior to the conventional ventilation strategy in improving the therapeutic effect of mechanical ventilation, reducing the incidence of VILI and VAP, and shortening the treatment time of mechanical ventilation in patients with PTB complicated with HIV infection.

Key words: Tuberculosis, pulmonary, HIV, Comorbidity, Respiration, artificial, Treatment outcome, Comparative study